-
and in vivo model systems, applying multiple omics methods. You will be working with clinical samples, method development and several molecular biology techniques, especially PCR and sequencing as
-
central role in conducting laboratory-based experimental work using clinical samples, with a particular emphasis on microRNA profiling and whole-genome or exome sequencing, including metagenomic approaches
-
systems, or network analysis. Experience with methods for causal inference, or modelling of biological systems is also considered a merit, along with prior work involving large-scale sequencing data such as
-
sequencing and synthesis to design useful cell behaviors. The scope of this project is to combine multi-gene control technology and computer algorithms to develop a foundational discovery platform for future
-
holder will have the opportunity to gain qualifications are: Data collection and curation. Whole genome sequence and annotation (coding and non-coding) from diverse plant species have been prepared, while
-
. The research involves: Microbiome sequencing and metagenomic mining to identify novel CIS candidates from diverse ecological niches (skin, gut, insect microbiomes) Recombinant expression and purification of CIS
-
genetically manipulated using CRISPR technology, in vitro. They will analyze cells and tumors through imaging, next generation DNA sequencing, single cell RNA sequencing, and other molecular techniques
-
-lab methods to profile RNA fragments from environmental samples. The methods will cover both next-generation sequencing-based methods but also targeted approaches such as qPCR and rolling circle
-
the orientation of various types of nanoparticles within both thermoset and thermoplastic polymer matrices. This position entails close collaboration with industrial partners to implement the alignment technique
-
to align the research with Mission 0 House's overall sustainability goals. The results will be presented in high-profile journals and conferences while you directly engage with industrial partners. The work